IP Library Granted Patent US 12,654,028
Granted Patent B2
US 12,654,028 · App. 19/289,856 · Granted Jun 16, 2026

Anti-infective and therapeutic electromagnetic emission methods and devices

Inventors: Mike Miskin (Sleepy Hollow, IL); Robert Kottritsch (Wixams, GB); Charles F. Huber (Lake Forest, IL); Allan Brent York (Langley, CA)
Assignee: SunInLyf Bio Inc.
A61N5/0624A61N5/067G06F3/013A61N2005/0626A61N2005/0648A61N2005/0651A61N2005/0659A61N2005/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,654,028
App. No.
19/289,856
Granted
Jun 16, 2026
Kind
B2
Abstract

A light emitting device for video displays with anti-infective and therapeutic electromagnetic emission methods and devices is disclosed. The light emitting device for video displays with anti-infective and therapeutic electromagnetic emission methods and devices uses non-visible and/or visible electromagnetic radiation on living species, including but not limited to people and animals, to provide treatments against infections and/or provide photobiomodulation treatments to improve health and wellness.

Claims (58)

1 . An electronic eyewear device for providing photobiomodulation (“PBM”) light therapy to a retina of a person wearing the electronic eyewear device, the electronic eyewear device comprising:

at least two cameras configured to capture video images;

at least two audio speakers configured to provide audio output;

at least one video display device;

a first plurality of light emitters configured to receive first control signals that cause the first plurality of light emitters to emit wavelengths of light for producing video images on the at least one video display device; and

a second plurality of light emitters configured to emit PBM wavelengths of light, wherein the PBM wavelengths of light comprise one or more PBM wavelengths of light within a range of 600 nm to 1400 nm known to stimulate mitochondria cells in humans and cause the mitochondria cells to produce additional ATP,

wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light for a controlled period of time before noon as it relates to a geographical location of the electronic eyewear device, and wherein the controlled period of time the PBM wavelengths of light are emitted totals at least two minutes before noon within a single day.

2 . The electronic eyewear device of claim 1 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within a range of 600 nm to 700 nm towards the retina.

3 . The electronic eyewear device of claim 1 , wherein the second plurality of light emitters is integrated into the at least one video display device.

4 . The electronic eyewear device of claim 1 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of lights through at least one optic that is configured to focus the PBM wavelengths of light into eyes of the person wearing the electronic eyewear device.

5 . The electronic eyewear device of claim 1 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to the electronic eyewear device receiving biological information related to the person wearing the electronic eyewear device, wherein the biological information is received from a remote electronic device.

6 . The electronic eyewear device of claim 1 , wherein the at least two audio speakers are bone conduction speakers.

7 . The electronic eyewear device of claim 1 , further comprising quantum dots.

8 . The electronic eyewear device of claim 1 , further comprising at least two lenses.

9 . An electronic eyewear device for providing photobiomodulation (“PBM”) light therapy to a retina of a person wearing the electronic eyewear device, the electronic eyewear device comprising:

at least two cameras configured to capture video images, wherein at least one of the at least two cameras is configured to be a front view facing camera and at least one of the at least two cameras is configured to be a rear view facing camera;

at least two audio speakers configured to provide audio output;

at least one video display device;

a first plurality of light emitters configured to receive first control signals that cause the first plurality of light emitters to emit wavelengths of light for producing video images on the at least one video display device; and

a second plurality of light emitters configured to emit PBM wavelengths of light, wherein the PBM wavelengths of light comprise one or more PBM wavelengths of light within a range of 600 nm to 1400 nm known to stimulate mitochondria cells in humans and cause the mitochondria cells to produce additional ATP,

wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light for a controlled period of time before noon as it relates to a geographical location of the electronic eyewear device, and wherein the controlled period of time the PBM wavelengths of light are emitted totals at least two minutes before noon within a single day.

10 . The electronic eyewear device of claim 9 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within a range of 600 nm to 700 nm towards the retina.

11 . The electronic eyewear device of claim 9 , further comprising a light emitter configured to emit the PBM wavelengths of light within a range of 750 nm to 1400 nm towards a temple of the person wearing the electronic eyewear device.

12 . The electronic eyewear device of claim 9 , wherein the second plurality of light emitters is integrated into the at least one video display device.

13 . The electronic eyewear device of claim 9 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to the electronic eyewear device receiving biological information related to the person wearing the electronic eyewear device, wherein the biological information is received from a remote electronic device.

14 . The electronic eyewear device of claim 9 , wherein the at least two audio speakers are bone conduction speakers.

15 . The electronic eyewear device of claim 9 , further comprising micro-LEDs.

16 . The electronic eyewear device of claim 9 , further comprising quantum dots.

17 . The electronic eyewear device of claim 9 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within the range of 600 nm to 1400 nm towards a face of the person for the controlled period of time at a specific time of day in response to the electronic eyewear device receiving data wirelessly from a wearable device worn by the person wearing the electronic eyewear device, and wherein the controlled period of time totals at least one consecutive minute before noon within the single day.

18 . The electronic eyewear device of claim 9 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within the range of 600 nm to 1400 nm towards eyes of the person through at least one optic that is configured to focus the PBM wavelengths of light into the eyes of the person wearing the electronic eyewear device while the person is viewing the video images on the electronic eyewear device.

19 . The electronic eyewear device of claim 9 , wherein at least 5% of the first plurality of light emitters are configured to only emit the PBM wavelengths of light within a range of 585 nm to 750 nm towards eyes of the person for a controlled constant duration of time at a specific time of day before noon.

20 . The electronic eyewear device of claim 9 , wherein the rear view facing camera is configured to be retractable.

21 . The electronic eyewear device of claim 9 , wherein at least one light emitter of the second plurality of light emitters is integrated within a frame of the electronic eyewear device.

22 . The electronic eyewear device of claim 9 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to the electronic eyewear device receiving biological information from a second device, wherein the biological information includes information related to the person wearing the electronic eyewear device and impacts second control signals received by the second plurality of light emitters emitting the PBM wavelengths of light.

23 . An electronic eyewear device for providing photobiomodulation (“PBM”) light therapy to a retina of a person wearing the electronic eyewear device, the electronic eyewear device comprising:

at least two cameras configured to capture video images, wherein at least one of the at least two cameras is configured to be a front view facing camera and at least one of the at least two cameras is configured to be a rear view facing camera;

at least two bone conduction audio speakers configured to provide audio output;

at least one video display device;

a first plurality of light emitters configured to receive first control signals that cause the first plurality of light emitters to emit wavelengths of light for producing video images on the at least one video display device; and

a second plurality of light emitters configured to emit PBM wavelengths of light, wherein the PBM wavelengths of light comprise one or more PBM wavelengths of light within a range of 600 nm to 1400 nm known to stimulate mitochondria cells in humans and cause the mitochondria cells to produce additional ATP,

wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light for a controlled period of time before noon as it relates to a geographical location of the electronic eyewear device, and wherein the controlled period of time the PBM wavelengths of light are emitted totals at least two minutes before noon within a single day.

24 . The electronic eyewear device of claim 23 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to data provided to the electronic eyewear device by a remote device that provides biofeedback information from the person wearing the electronic eyewear device, and wherein the data impacts a control of the emission of the PBM wavelengths of light.

25 . The electronic eyewear device of claim 23 , further comprising at least one optic configured to focus the PBM wavelengths of light towards at least one eye or a temple of the person wearing the electronic eyewear device.

26 . The electronic eyewear device of claim 23 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light when the at least one video display device is displaying the video images.

27 . An electronic eyewear device for providing photobiomodulation (“PBM”) light therapy to a retina of a person wearing the electronic eyewear device, the electronic eyewear device comprising:

at least one video display device;

at least two cameras configured to capture video images;

at least two audio speakers configured to provide audio output; and

a plurality of light emitters configured to receive first control signals that cause the plurality of light emitters to emit wavelengths of light for producing video images on the at least one video display device,

wherein a percentage of the plurality of light emitters are configured to only emit PBM wavelengths of light within a range of 585 nm to 750 nm for a controlled period of time before noon as it relates to a geographical location of the electronic eyewear device, and wherein the controlled period of time the PBM wavelengths of light are emitted totals at least one minute before noon within a single day.

28 . The electronic eyewear device of claim 27 , further comprising a software application configured to control at least one of:

a percentage of light emitters that emit the PBM wavelengths of light,

which of the light emitters emit the PBM wavelengths of light,

the time of day the light emitters emit the PBM wavelengths of light,

energy levels the light emitters emitting the PBM wavelengths of light, and

a duration of time the light emitters emit the PBM wavelengths of light.

29 . The electronic eyewear device of claim 27 , wherein the electronic eyewear device is configured to be in wireless communication with another electronic communications device.

30 . The electronic eyewear device of claim 27 , wherein the PBM wavelengths of light are emitted into eyes of the person wearing the electronic eyewear device while the person is viewing the video images on the electronic eyewear device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2025
From: MISKIN, MIKE; KOTTRITSCH, ROBERT; HUBER, CHARLES F.; YORK, ALLAN BRENT
To: SUNINLYF BIO LLC
Reel/Frame 072576/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2025
From: SUNINLYF BIO LLC
To: SUNINLYF BIO INC.
Reel/Frame 072576/0540 →
Continuity (6)
Continuation 18424513 · Jan 26, 2024
Provisional Application 63630055 · Dec 26, 2023
Provisional Application 63457039 · Apr 4, 2023
Provisional Application 63489139 · Mar 8, 2023
Provisional Application 63481742 · Jan 26, 2023
Related Publication 20250360336A1 · Nov 27, 2025
References Cited (178)
US 4595491A · Berns · 1986 [cited by applicant]
US 5766233A · Rolf · 1998 [cited by applicant]
US 5913883A · Alexander et al. · 1999 [cited by applicant]
US 6019482A · Randall · 2000 [cited by applicant]
US 6269818B1 · Harvey et al. · 2001 [cited by applicant]
US 6350275B1 · Vreman et al. · 2002 [cited by applicant]
US 6488698B1 · Hyman · 2002 [cited by applicant]
US 6673095B2 · Nordquist · 2004 [cited by applicant]
US 6875225B1 · Pederson · 2005 [cited by applicant]
US 7348736B2 · Piepgras et al. · 2008 [cited by applicant]
US 7517344B2 · Vam Hal et al. · 2009 [cited by applicant]
US 7559945B2 · Breden et al. · 2009 [cited by applicant]
US 7648649B2 · Radkov · 2010 [cited by applicant]
US 7686839B2 · Parker · 2010 [cited by applicant]
US 8506612B2 · Ashdown · 2013 [cited by applicant]
US 9079022B2 · Baird et al. · 2015 [cited by applicant]
US 9289622B2 · Feng et al. · 2016 [cited by applicant]
US 9410664B2 · Krames · 2016 [cited by applicant]
US 9415237B2 · Giovanna et al. · 2016 [cited by applicant]
US 9526860B2 · Baaijens et al. · 2016 [cited by applicant]
US 9579521B2 · Ferraz Rigo et al. · 2017 [cited by applicant]
US 9662067B2 · Gimenez et al. · 2017 [cited by applicant]
US 9719660B1 · Petluri et al. · 2017 [cited by applicant]
US 9808644B2 · Daffer · 2017 [cited by applicant]
US 9844116B2 · Soler et al. · 2017 [cited by applicant]
US 9867255B2 · Wouter et al. · 2018 [cited by applicant]
US 10009974B2 · Bremser et al. · 2018 [cited by applicant]
US 10322297B1 · Hinds et al. · 2019 [cited by applicant]
US 10471231B2 · Moore-Ede et al. · 2019 [cited by applicant]
US 10492264B2 · Petluri et al. · 2019 [cited by applicant]
US 10632214B2 · David et al. · 2020 [cited by applicant]
US 10750591B2 · Petluri et al. · 2020 [cited by applicant]
US 10900615B2 · Krames et al. · 2021 [cited by applicant]
US 11073727B2 · David · 2021 [cited by applicant]
US 11102863B2 · Raghuram et al. · 2021 [cited by applicant]
US 11168250B2 · Petluri et al. · 2021 [cited by applicant]
US 11191140B2 · Petluri et al. · 2021 [cited by applicant]
US 11198020B2 · Petluri et al. · 2021 [cited by applicant]
US 11198813B2 · Raghuram et al. · 2021 [cited by applicant]
US 11265983B2 · Raghuram et al. · 2022 [cited by applicant]
US 11287692B1 · Pickard et al. · 2022 [cited by applicant]
US 11308849B2 · Petluri et al. · 2022 [cited by applicant]
US 11338107B2 · Allen et al. · 2022 [cited by applicant]
US 11371660B2 · Raghuram et al. · 2022 [cited by applicant]
US 11511071B2 · Krames et al. · 2022 [cited by applicant]
US 11552278B2 · Jo et al. · 2023 [cited by applicant]
US 11783748B2 · Petluri et al. · 2023 [cited by applicant]
US 20020015013A1 · Ragle · 2002 [cited by applicant]
US 20030009158A1 · Perricone · 2003 [cited by applicant]
US 20030189829A1 · Shimizu et al. · 2003 [cited by applicant]
US 20040011132A1 · Netzel · 2004 [cited by applicant]
US 20040147984A1 · Altshuler et al. · 2004 [cited by applicant]
US 20040162549A1 · Altshuler · 2004 [cited by applicant]
US 20040210277A1 · Becker et al. · 2004 [cited by applicant]
US 20040225339A1 · Yaroslavsky et al. · 2004 [cited by applicant]
US 20040230259A1 · De Matteo · 2004 [cited by applicant]
US 20050128751A1 · Roberge et al. · 2005 [cited by applicant]
US 20050177139A1 · Yamazaki et al. · 2005 [cited by applicant]
US 20050222555A1 · Manstein et al. · 2005 [cited by applicant]
US 20060009822A1 · Savage et al. · 2006 [cited by applicant]
US 20060030908A1 · Powell et al. · 2006 [cited by applicant]
US 20060200212A1 · Brawn · 2006 [cited by applicant]
US 20060217586A1 · Van Hal et al. · 2006 [cited by applicant]
US 20070027510A1 · Rodrigues et al. · 2007 [cited by applicant]
US 20070086912A1 · Dowling et al. · 2007 [cited by applicant]
US 20070115658A1 · Mueller et al. · 2007 [cited by applicant]
US 20070219605A1 · Yaroslavsky et al. · 2007 [cited by applicant]
US 20080275533A1 · Powell · 2008 [cited by applicant]
US 20090054953A1 · Whitehurst · 2009 [cited by applicant]
US 20090204185A1 · De Kok et al. · 2009 [cited by applicant]
US 20090281604A1 · Do Boer et al. · 2009 [cited by applicant]
US 20090326616A1 · Aarts et al. · 2009 [cited by applicant]
US 20100105022A1 · Kuiper et al. · 2010 [cited by applicant]
US 20100171441A1 · Schlangen et al. · 2010 [cited by applicant]
US 20100174345A1 · Ashdown · 2010 [cited by applicant]
US 20120088204A1 · Ho et al. · 2012 [cited by applicant]
US 20120095534A1 · Schlangen et al. · 2012 [cited by applicant]
US 20120253432A1 · Loveland · 2012 [cited by applicant]
US 20130131762A1 · Oversluizen et al. · 2013 [cited by applicant]
US 20130147400A1 · Van Herpen et al. · 2013 [cited by applicant]
US 20130190845A1 · Liu et al. · 2013 [cited by applicant]
US 20130218240A1 · Feng et al. · 2013 [cited by applicant]
US 20130238060A1 · Nevins · 2013 [cited by applicant]
US 20140128941A1 · Williams · 2014 [cited by applicant]
US 20140265926A1 · Hu et al. · 2014 [cited by applicant]
US 20150039060A1 · Paulussen et al. · 2015 [cited by applicant]
US 20150039061A1 · Hong et al. · 2015 [cited by applicant]
US 20150051672A1 · Jo et al. · 2015 [cited by applicant]
US 20150231408A1 · Williams et al. · 2015 [cited by applicant]
US 20150238120A1 · Shan et al. · 2015 [cited by applicant]
US 20150283399A1 · Guglielmi et al. · 2015 [cited by applicant]
US 20150343235A1 · Blanche et al. · 2015 [cited by applicant]
US 20160076736A1 · Van Bommel et al. · 2016 [cited by applicant]
US 20160116124A1 · Podowitz et al. · 2016 [cited by applicant]
US 20160317833A1 · Tedford et al. · 2016 [cited by applicant]
US 20170231058A1 · Sadwick · 2017 [cited by applicant]
US 20170361124A1 · Parker et al. · 2017 [cited by applicant]
US 20180077767A1 · Soler et al. · 2018 [cited by applicant]
US 20180092521A1 · Nolan et al. · 2018 [cited by applicant]
US 20180154172A1 · Kalmeta · 2018 [cited by applicant]
US 20180160491A1 · Biery et al. · 2018 [cited by applicant]
US 20180318599A1 · Van Bommel et al. · 2018 [cited by applicant]
US 20190167400A1 · Barnes et al. · 2019 [cited by applicant]
US 20190280717A1 · Jeong et al. · 2019 [cited by applicant]
US 20190348628A1 · Hack et al. · 2019 [cited by applicant]
US 20200146120A1 · Petluri et al. · 2020 [cited by applicant]
US 20200260546A1 · Petluri et al. · 2020 [cited by applicant]
US 20200298016A1 · Yoon et al. · 2020 [cited by applicant]
US 20210060353A1 · Raghuram et al. · 2021 [cited by applicant]
US 20210125907A1 · Huang et al. · 2021 [cited by applicant]
US 20210136887A1 · Raghuram et al. · 2021 [cited by applicant]
US 20210227657A1 · Petluri et al. · 2021 [cited by applicant]
US 20210242182A1 · Yamakawa et al. · 2021 [cited by applicant]
US 20210251060A1 · Petluri et al. · 2021 [cited by applicant]
US 20210290973A1 · Moore-ede et al. · 2021 [cited by applicant]
US 20210315083A1 · Harrison et al. · 2021 [cited by applicant]
US 20210338861A1 · Harrison et al. · 2021 [cited by applicant]
US 20210402210A1 · Raghuram et al. · 2021 [cited by applicant]
US 20220001200A1 · Petluri et al. · 2022 [cited by applicant]
US 20220005404A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220036793A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220180803A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220264717A1 · Parker et al. · 2022 [cited by applicant]
US 20220272806A1 · Petluri et al. · 2022 [cited by applicant]
US 20220272820A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220288412A1 · Honold et al. · 2022 [cited by applicant]
US 20220323785A1 · Petluri · 2022 [cited by examiner]
US 20220334305A1 · Harrison et al. · 2022 [cited by applicant]
US 20220404667A1 · Pickard et al. · 2022 [cited by applicant]
US 20230285771A1 · Petluri et al. · 2023 [cited by applicant]
US 20230324035A1 · Maa et al. · 2023 [cited by applicant]
AU 2021374233 · 2023 [cited by applicant]
CN 109417841 · 2019 [cited by applicant]
DE 202018005328 · 2019 [cited by applicant]
DK 2874701 · 2018 [cited by applicant]
EP 3504942 · 1990 [cited by applicant]
EP 2094064 · 2009 [cited by applicant]
EP 2164568 · 2010 [cited by applicant]
EP 2348246 · 2011 [cited by applicant]
EP 2905544 · 2015 [cited by applicant]
EP 3427660 · 2019 [cited by applicant]
EP 3668276 · 2020 [cited by applicant]
EP 4067729 · 2022 [cited by applicant]
EP 4190367 · 2023 [cited by applicant]
JP 5937016 · 2013 [cited by applicant]
JP 2020505787 · 2020 [cited by applicant]
KR 20070043085 · 2007 [cited by applicant]
KR 20070045382 · 2007 [cited by applicant]
KR 100973078 · 2010 [cited by applicant]
KR 20110081213 · 2011 [cited by applicant]
KR 20120050781 · 2012 [cited by applicant]
KR 102571122 · 2023 [cited by applicant]
KR 102571168 · 2023 [cited by applicant]
KR 102571173 · 2023 [cited by applicant]
KR 102571180 · 2023 [cited by applicant]
KR 102571189 · 2023 [cited by applicant]
KR 102571194 · 2023 [cited by applicant]
KR 102571272 · 2023 [cited by applicant]
KR 102571273 · 2023 [cited by applicant]
KR 102571274 · 2023 [cited by applicant]
KR 102571277 · 2023 [cited by applicant]
KR 102592001 · 2023 [cited by applicant]
KR 102592005 · 2023 [cited by applicant]
RU 155992 · 1985 [cited by applicant]
WO 9000458 · 1990 [cited by applicant]
WO 2008069101 · 2010 [cited by applicant]
WO 2012021243 · 2012 [cited by applicant]
WO 2015184019 · 2015 [cited by applicant]
WO 2016037994 · 2016 [cited by applicant]
WO 2016146688 · 2016 [cited by applicant]
WO 2017210461 · 2017 [cited by applicant]
WO 2016208683 · 2018 [cited by applicant]
WO 2018130403 · 2018 [cited by applicant]
WO 2019139635 · 2019 [cited by applicant]
WO 2019140306 · 2019 [cited by applicant]
WO 2020097575 · 2020 [cited by applicant]
WO 2022200131 · 2022 [cited by applicant]
European Office Action—Application No. 21792152.7 dated Mar. 22, 2024—9 pages. [cited by applicant]